Opioid Policies
Much like the rest of the United States, residents of the District of Columbia are struggling with substance use disorder (SUD) rate increases and high rates of opioid-related deaths. Unfortunately, these are multi-faceted issues that require year-long initiatives and systematic programs to address the myriad causes of addiction.
MSDC stands as a partner to the District government and private entities to help arrest the rates of opioid and substance abuse in the District. Through our advocacy for better prescribing practices, education on addiction, and even helping our own community through our Physician Health Program, MSDC is working to make DC a leader in reducing SUD, OUD, and addiction.
On a related note, MSDC is passionate about helping patients make prescriptions and medication more affordable. Whether expanding access to biosimilars or advocating for more affordable co-pays, MSDC wants to help our patients afford the medications they need.
MSDC Statement and Testimony on Opioid and Prescription Issues
25th Council information coming soon
September 20 is MSDC Day of Action on Prior Auth and Copay Accumulators
It's time for the DC Council to hear the physician community speak at once on the biggest prescription issues impacting our patients.
MSDC and our partners are launching a day of action on two critical bills that if passed could radically change medicine in DC for the better. Both bills are top priority for the Society and our members, and bills that are widely supported by physicians.
We are asking you, your practice managers, your staff, and patients to contact the DC Council on September 20 and push the Council to pass this year two bills:
- B24-655, the Prior Authorization Reform Act. This bill would improve the prior authorization process by setting limits on who, when, and how payers can slap prior auths on our medical decisions. This bill has not had a hearing and needs to have a hearing to pass committee.
- B24-557, the Copay Accumulators Amendment Act. This bill prevents insurers from penalizing patients from using coupons and discounts for specialty drugs. This bill had a hearing - with testimony overwhelmingly in favor - but needs a mark-up to go to the full Council.
How can you participate in the Day of Action? It's easy, not time consuming, and fits into your busy schedule. And MSDC will help:
- Look up who are the Councilmembers for your home (if you're a DC resident) and/or practice. You can find your Ward here. Remember your location is represented by your Ward Councilmember, at-large Councilmembers, and the Council Chair.
- Email your Councilmembers and their staff asking them to support either or both bills (if they are not already a supporter) and support them being added to the Council agenda this year after markup in the Health Committee.
- You can also call your Councilmembers with the same ask. Call the office number and ask to speak to the Councilmember or staff person for the issue.
- If you have time, visit your members' offices. Be aware there are visitor restrictions at the Wilson Building.
- Let MSDC know who you contact by emailing hay@msdc.org
Sample of Legislation MSDC Tracked on Opioid and Prescription Policy
What does it do? The bill authorizes licensed pahrmacists to dispense interchangeable biological products and requires notifications to physicians when such interchangeables are dispensed.
MSDC position: MSDC has a position of priority support on this legislation, identifying its passage as one of its highest legislative priorities.
Current status: SUCCESS. The bill was passed by the Council and signed by the Mayor.
What does it do? The bill requires prescription opioid medications to include a statement that the drug is an opioid and opioids may cause dependence, addiction, or overdoes.
MSDC position: MSDC supports the legislation.
Current status: The bill had a hearing before the Committee on Health on July 29, 2020. MSDC leader Dr. Sam Kareff testified for the Medical Society. It passed the Council on November 10 and was signed by the Mayor December 7.
What does it do? The bill prohibits insurance companies from factoring the use of PreP in decisions related to disability, life, or long-term care policies.
MSDC position: MSDC supports this legislation
Current status: The bill was introduced on January 8, 2019 and assigned to the Committee on Business and Economic Development.